[go: up one dir, main page]

WO2003014304A3 - Formulation protonique - Google Patents

Formulation protonique Download PDF

Info

Publication number
WO2003014304A3
WO2003014304A3 PCT/US2002/024662 US0224662W WO03014304A3 WO 2003014304 A3 WO2003014304 A3 WO 2003014304A3 US 0224662 W US0224662 W US 0224662W WO 03014304 A3 WO03014304 A3 WO 03014304A3
Authority
WO
WIPO (PCT)
Prior art keywords
protonic
formulation
amino acids
activation
adjusters
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2002/024662
Other languages
English (en)
Other versions
WO2003014304A2 (fr
Inventor
Michael Ernest
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Doctor's Signature Sales and Marketing International Corp (DBA Life Force International
Original Assignee
Doctor's Signature Sales and Marketing International Corp (DBA Life Force International
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Doctor's Signature Sales and Marketing International Corp (DBA Life Force International filed Critical Doctor's Signature Sales and Marketing International Corp (DBA Life Force International
Priority to AU2002355542A priority Critical patent/AU2002355542A1/en
Publication of WO2003014304A2 publication Critical patent/WO2003014304A2/fr
Publication of WO2003014304A3 publication Critical patent/WO2003014304A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/185—Vegetable proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicinal Preparation (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

L'invention concerne un mélange protonique stabilisé de formulation protonique (Figure 2A) comprenant principalement des protéines (Figure 2A), des enzymes et des agents d'équilibration du pH (Figure 2A), dans des rapports spécifiques les uns par rapport aux autres; un milieu liquide qui, lors qu'il est combiné à la formulation protonique, amorce l'activation des amino acides dans la formulation protonique; ainsi qu'un composant de stabilisation stabilisant les amino acides au cours du processus d'activation.
PCT/US2002/024662 2001-08-09 2002-08-02 Formulation protonique Ceased WO2003014304A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2002355542A AU2002355542A1 (en) 2001-08-09 2002-08-02 Protonic formulation

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US31128001P 2001-08-09 2001-08-09
US60/311,280 2001-08-09

Publications (2)

Publication Number Publication Date
WO2003014304A2 WO2003014304A2 (fr) 2003-02-20
WO2003014304A3 true WO2003014304A3 (fr) 2003-05-01

Family

ID=23206195

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2002/024662 Ceased WO2003014304A2 (fr) 2001-08-09 2002-08-02 Formulation protonique

Country Status (2)

Country Link
AU (1) AU2002355542A1 (fr)
WO (1) WO2003014304A2 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
BRPI0917807A2 (pt) 2008-08-15 2019-11-19 Forest Laboratories Holdings Ltd formulação sólida estável de um polipeptídeo agonista de recepto gc-c adequada para administração oral
US8748573B2 (en) 2009-08-06 2014-06-10 Ironwood Pharmaceuticals, Inc. Formulations comprising linaclotide
CA2790213A1 (fr) 2010-02-17 2011-08-25 Ironwood Pharmaceuticals, Inc. Traitements de troubles gastro-intestinaux
MX348823B (es) 2010-08-11 2017-06-30 Forest Laboratories Holdings Ltd Formulaciones estables de linaclotida.
HUE032237T2 (en) 2011-08-17 2017-09-28 Ironwood Pharmaceuticals Inc Treatments for gastrointestinal disorders
CN111066776A (zh) * 2019-11-09 2020-04-28 无锡市人民医院 一种卵子冷冻保护剂及其应用

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1107824A (en) * 1964-06-16 1968-03-27 Mauvernay Roland Yves Effervescent enzyme compositions

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1107824A (en) * 1964-06-16 1968-03-27 Mauvernay Roland Yves Effervescent enzyme compositions

Also Published As

Publication number Publication date
AU2002355542A1 (en) 2003-02-24
WO2003014304A2 (fr) 2003-02-20

Similar Documents

Publication Publication Date Title
WO2001062280A3 (fr) Composition contenant une lipase et ses procedes d'utilisation
WO2001075087A8 (fr) Variantes de lasubtilisine
CA2322311A1 (fr) Inhibiteurs de la proteine tyrosine kinase, a base d'imidazopyrazine a substitution heterocyclo
HUP0500163A3 (en) Pyrazolo [5,1-b]quinazoline derivatives and pharmaceutical compositions thereof as inhibitors of impdh enzyme
WO2003029420A3 (fr) Variants de ligands apo-2 et leurs utilisations
WO1998014592A3 (fr) Transcriptase inverse de la telomerase
AU2007301A (en) Solid mixture consisting of foodstuff ingredients and foodstuff additives, method for the production thereof, and their use
ZA989014B (en) Process for the microbial production of amino acids of the aspartate and/or glutamate family and means used in the process.
AU2003259112A1 (en) Enzymatic process for the preparation of foods, feedstuffs and ingredients therefor
WO2002049452A3 (fr) Concentres d'arome
WO2003014304A3 (fr) Formulation protonique
WO2002039828A3 (fr) Procede
WO2003040181A3 (fr) Genes codant des proteines de regulation
CA2438622A1 (fr) Compositions contenant de la creatine et de la creatinine
WO2004039174A3 (fr) Procede
WO2003059323A3 (fr) Sels stables d'acide o-acetylsalicylique contenant des acides amines ii basiques
WO2001064837A3 (fr) NETRINE β ET SES UTILISATIONS
WO2003032747A1 (fr) Aliments contenant une proteine animale, procede de ramollissement de la proteine animale, et ramollissants utilisables pour ramollir la proteine animale
WO2002026929A3 (fr) Proteine moteur kini-3 et methodes d'utilisation associees
AU2002358381A1 (en) Method and kit providing bioadhesive binding or coating with polyphenolic mussel proteins
WO2001046463A3 (fr) Methodes de preparation et d'utilisation d'etalons internes destines a des dosages par amplification de l'acide nucleique
WO2003000901A8 (fr) Acides nucleiques codant des proteines kinases
WO2003070878A3 (fr) Modulation anti-sens de l'expression des proteines tyrosine kinase de cellules hematopoietiques
WO2001053352A3 (fr) Proteines specifiques du sperme
WO1999067283A8 (fr) Polypeptides, polynucleotides et leurs utilisations

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BY BZ CA CH CN CO CR CU CZ DE DM DZ EC EE ES FI GB GD GE GH HR HU ID IL IN IS JP KE KG KP KR LC LK LR LS LT LU LV MA MD MG MN MW MX MZ NO NZ OM PH PL PT RU SD SE SG SI SK SL TJ TM TN TR TZ UA UG US UZ VN YU ZA ZM

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ UG ZM ZW AM AZ BY KG KZ RU TJ TM AT BE BG CH CY CZ DK EE ES FI FR GB GR IE IT LU MC PT SE SK TR BF BJ CF CG CI GA GN GQ GW ML MR NE SN TD TG

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP